HoldingsChannel.com
Aisling Capital Management LP Top Holdings
As of  06/30/2019

   EntityAmountChange
 03/31/2019 to 06/30/2019
Position Size
($ in 1000's)
BridgeBio BBIO 3,835,722 +3,835,722 $103,449
     BBIO3,835,722+3,835,722$103,449
Eidos Therapeutics Inc. EIDIX 1,123,630 UNCH $34,922
     EIDX1,123,630UNCH$34,922
Marker Therapeutics Inc. MRKR 2,000,000 UNCH $15,840
     MRKR2,000,000UNCH$15,840
ObsEva SA OBSV 1,386,338 UNCH $15,679
     OBSV1,386,338UNCH$15,679
AVROBIO Inc. AVRO 811,998 UNCH $13,203
     AVRO811,998UNCH$13,203
Biohaven Pharmaceutical Holding Company Ltd. BHVN 274,513 UNCH $12,021
     BHVN274,513UNCH$12,021
Aeglea Biotherapeutics Inc AGLE 1,291,151 +70,240 $8,844
     AGLE1,291,151+70,240$8,844
Atreca BCEL 387,653 +387,653 $7,303
     BCEL387,653+387,653$7,303
Zosano Pharma Corporation ZSAN 2,028,571 +428,571 $6,633
     ZSAN2,028,571+428,571$6,633
Sunesis Pharmaceuticals Inc. SNSS 7,600,000 UNCH $5,548
     SNSS7,600,000UNCH$5,548
Nabriva Therapeutics plc NBRV 1,809,259 UNCH $4,396
     NBRV1,809,259UNCH$4,396
Arcus Biosciences Inc. RCUS 333,333 UNCH $2,650
     RCUS333,333UNCH$2,650
Verona Pharma plc VRNA 443,596 UNCH $2,262
     VRNA443,596UNCH$2,262

See Full List: All Stocks Held By Aisling Capital Management LP
— Including:
     • Biggest new positions
     • Biggest exits
     • Biggest increased positions
     • Biggest decreased positions

See Details: Top 10 Stocks Held By Aisling Capital Management LP

Size ($ in 1000's)
At 06/30/2019: $234,139
At 03/31/2019: $131,269

Aisling Capital Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Aisling Capital Management LP 13F filings. Link to 13F filings: SEC filings

Aisling Capital Management LP Top Holdings 13F Filings | www.HoldingsChannel.com

Copyright © 2013 - 2019, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.